Challenges in estimating the impact of pneumococcal conjugate vaccines through surveillance.

Vergison, Anne; Hanquet, Germaine

Vergison, Anne; Hanquet, Germaine.

Affiliation

Vergison A; Paediatric Infectious Diseases Unit, Epidemiology and Infection Control Unit, Université Libre de Bruxelles, HUDERF, Brussels, Belgium. anne.vergison@huderf.be

Pediatr Infect Dis J ; 31(4): 400-3, 2012 Apr.

Article in En | MEDLINE | ID: mdl-22418653

Subject(s)

Pneumococcal Infections/epidemiology; Pneumococcal Infections/prevention & control; Pneumococcal Vaccines/administration & dosage; Pneumococcal Vaccines/immunology; Population Surveillance/methods; Bacteriological Techniques/methods; Europe/epidemiology; Heptavalent Pneumococcal Conjugate Vaccine; Humans; Incidence; Streptococcus pneumoniae/classification; Streptococcus pneumoniae/isolation & purification; Vaccines, Conjugate/administration & dosage; Vaccines, Conjugate/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumococcal Infections / Population Surveillance / Pneumococcal Vaccines Type of study: Incidence_studies / Prognostic_studies / Screening_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Pediatr Infect Dis J Journal subject: DOENCAS TRANSMISSIVEIS / PEDIATRIA Year: 2012 Document type: Article Affiliation country: Belgium

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google